Endologix Inc's ROA from the second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Endologix Inc's ROA in the second quarter of 2020?
Endologix Inc recorded a cumulative net loss of $-60 million during 12 months ending in the second quarter of 2020, resulting in a negative return on assets (ROA) of -19.99%.

However, within the Healthcare sector 343 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2020 quarter, so far to 3679, from total ROA ranking in the first quarter of 2020 at 3729.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter
Y / Y Total Assets Change	-16.31 %	3.75 %	4.81 %	-2.7 %	-2.83 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-60	-61	-65	-83	-85
Return On Assets (TTM)	-19.99 %	-19.48 %	-20.92 %	-27.08 %	-27.65 %
ELGX's Total Ranking	# 3679	# 3729	# 4271	# 3964	# 4014
Total Assets (TTM) in million	271	300	307	318	324
Seq. Total Assets Change	-9.63 %	-2.22 %	-3.26 %	-2.09 %	12.02 %
Seq. Net Income Change	-	-	-	-	-

ELGX's 5 Years Annual ROA >> Back to ELGX Management Effectiveness >> Compare ELGX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 104
Sector	# 344
Overall	# 3556

Return On Assets Statistics
High	Average	Low
-2.3 %	-21.06 %	-41.52 %
(Mar 31 2014)		(Jun 30 2016)

Financial Statements
Endologix Inc's Assets	$ 271 million	ELGX's Balance sheet
Endologix Inc's Income	$ -26 million	Quarterly ELGX's Income Statement
ELGX's Income by Division		See ELGX's Income by Division

Annual Return On Assets	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2016) FY 2016	(Dec 31 2015) FY 2015
Y / Y Total Assets Change	4.81 %	-19.72 %	1.49 %	7.11 %	35.3 %
Total Assets in million	307	293	365	360	336
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-65	-80	-66	-155	-50
Annual Return On Assets	-21.08 %	-27.2 %	-18.19 %	-43 %	-15.02 %

ELGX's 5 Years Annual ROA >> Back to ELGX Management Effectiveness >> Compare ELGX ROA to its Competitors

More Return On Assets Ratios
ELGX's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ELGX's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ELGX's Competitors
Subscribers only: Roa for Endologix Inc's Suppliers
Subscribers only: Return On Assets for ELGX's Customers

You may also want to know
ELGX's Roi	ELGX's Inventory Turnover Ratio	ELGX's Growth Rates	ELGX's Dividend Comparisons
	ELGX's Profitability Ratios	ELGX's Asset Turnover Ratio	ELGX's Dividend Growth
ELGX's Roe	ELGX's Valuation Ratios	ELGX's Financial Strength Ratios	ELGX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2020, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:10:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.